Breast cancer cells in the blood: A pilot study

Breast Journal

Volumn 5, Issue 6, 1999, Pages 354-358

  Krag, D N ^a,k   Ashikaga, T ^a   Moss, T J ^b   Kusminsky, R E ^c   Feldman, S ^d   Carp, Ned Z ^e   Moffat Jr , F L ^f   Beitsch, P D ^g   Frazier, T G ^h   Gaskin, T A ⁱ   Shook, J W ^j   Harlow, S P ^a   Weaver, D L ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b BIS Laboratories   (United States)

^c CHARLESTON AREA MEDICAL CENTER   (United States)

^d Benedictine Hospital   (United States)

^e Main Line Surgeons Ltd   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g St Paul University Hospital   (United States)

^h BRYN MAWR HOSPITAL   (United States)

ⁱ Surgeons Group PC   (United States)

^j UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^k UNIVERSITY OF VERMONT   (United States)

more..

Author keywords

Antibody; Blood; Breast; Cancer; Dissemination; Metastases

Indexed keywords

KERATIN;

ADULT; ARTICLE; BREAST CANCER; CANCER RECURRENCE; CELL COUNT; CELL SEPARATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; EARLY DIAGNOSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MONONUCLEAR CELL; PILOT STUDY;

EID: 6544295358     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.1999.99016.x     Document Type: Article

References (15)

1. Halsted W. The results of radical operations for the cure of carcinoma of the breast. Ann Surg 1907;46:1.
2. Fisher B. Biological and clinical considerations regarding the use of surgery and chemotherapy in the treatment of primary breast cancer. Cancer 1977;40:574-87.
3. McQuire WL. Prognostic factors and treatment decisions in axillary-node-negative breast cancer. N Engl J Med 1992;326:1756-61.
4. Singleton TP. Clinical and pathologic significance of c-erbB-2 (HER-2/neu) oncogene. Pathol Annu 1992;27:165-90.
5. Thor AD, Edgerton SM, Kawasaki ES, et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992; 84:845-55.
6. Brandt B, Roetger A, Heidl S, et al. Isolation of blood-borne epithelium-derived c-erbB-2 oncoprotein-positive clustered cells from the peripheral blood of breast cancer patients. Int J Cancer 1998;76:824-28.
7. Eaton MC, Hardingham JE, Kotasek D, Dobrovic A. Immunobead RT-PCR: a sensitive method for detection of circulating tumor cells. Biotechniques 1997;22:100-105.
8. Hildebrandt M, Mapara MY, Korner IJ, Bargou RC, Moldenhauer G, Dorken B. Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency. Exp Hematol 1997;25:57-65.
9. Naume B, Borgen E, Beiske K, et al. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 1997;6:103-14.
10. Racila E, Euhus D, Weiss AJ, et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998;95:4589-94.
11. Rostagno P, Moll JL, Bisconte JC, Caldani C. Detection of rare circulating breast cancer cells by filtration cytometry and identification by DNA content: sensitivity in an experimental model. Anticancer Res 1997;17:2481-85.
12. Hoover HC Jr, Ketcham AS. Techniques for inhibiting tumor metastases. Cancer 1975;35:5-14.
13. 27-deoxyuridine. J Natl Cancer Inst 1970;45:773.
14. Butler TP, Gullino PM. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 1975;35:512-16.
15. Weiss L. Metastatic inefficiency. Adv Cancer Res 1990;54:159-211.